Feb 26, 2026 06:00AM
Feb 19, 2026 06:00AM
Nov 4, 2025 06:00AM
Nov 3, 2025 06:00AM
Oct 15, 2025 06:01AM
Oct 15, 2025 06:00AM
Sep 30, 2025 05:01AM Aurinia defends LUPKYNIS after FDA official retracts LinkedIn post
Sep 30, 2025 02:37AM
Sep 29, 2025 08:27PM
Jul 31, 2025 06:00AM
Jul 30, 2025 06:34AM
Jul 22, 2025 06:00AM
Jun 30, 2025 06:01AM
Jun 30, 2025 06:00AM Aurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)
Jun 29, 2025 05:00PM
May 22, 2025 06:00AM
May 12, 2025 06:00AM
May 5, 2025 06:00AM
Apr 30, 2025 06:00AM
Apr 29, 2025 06:00AM
Feb 27, 2025 06:00AM Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress
Feb 20, 2025 04:05PM
Nov 18, 2024 05:53PM
Nov 15, 2024 06:00AM
Nov 14, 2024 06:00AM
Nov 7, 2024 06:10AM
Nov 7, 2024 06:10AM
Nov 7, 2024 06:00AM Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS® Growth and AUR200 Devel
Oct 30, 2024 04:05PM
Oct 11, 2024 06:01AM
Oct 11, 2024 06:00AM
Sep 24, 2024 08:10AM
Sep 24, 2024 08:10AM
Sep 13, 2024 06:00AM
Sep 12, 2024 04:05PM Aurinia Pharmaceuticals (AUPH) Announces Board Restructuring
Sep 12, 2024 04:05PM
Sep 6, 2024 06:53AM
Sep 5, 2024 07:22AM
Sep 5, 2024 06:00AM
Aug 28, 2024 06:00AM
Aug 1, 2024 08:00AM
Aug 1, 2024 06:00AM Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results
Jul 19, 2024 06:00AM
Jul 2, 2024 06:00AM
Jun 14, 2024 12:16PM
Jun 5, 2024 06:02AM
Jun 5, 2024 06:00AM
Jun 4, 2024 05:30PM
Jun 3, 2024 06:30PM Aurinia Provides Update on Proxy Statement
May 30, 2024 06:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All